Portfolio News

‘Digital pill’ maker Proteus Digital Health files for bankruptcy

Proteus Digital Health, the maker of an ingestible sensor for tracking medication adherence, filed for Chapter 11 bankruptcy protection on June 15, 2020.  In addition, Andrew Thompson stepped down as the company’s CEO, replaced by Lawrence Perkins of SierraConstellation Partners, who had previously been hired as Proteus’s chief restructuring officer. “Filing for bankruptcy protection allows Proteus to continue its sales process in a more concerted and efficient manner while continuing to run the business as usual,” Proteus said in a statement provided to MobiHealthNews. The news didn’t...

Walmart buys tech from CareZone to help people manage their prescriptions

Walmart is acquiring technology and intellectual property from CareZone, a startup that makes it easier for people to manage multiple medications, Walmart confirmed to CNBC. CareZone got its start in 2010. It develops apps to help people manage their medicines. The company also developed technology that allows users to scan insurance cards and prescription drug labels so patients can more easily figure out what their health plan covers and arrange home deliveries. Walmart will now take possession of these assets. In addition, 25 to 30 CareZone engineering...

Augmedix Announces New Board Member, Jennifer M. Carter

Augmedix has announced that Jennifer M. Carter, Vice President, Venture Operations at McKesson Ventures, will join its board of directors. At McKesson Ventures, Carter leads a team responsible for investing, fund management, portfolio development, marketing, and PR. She has more than 20 years of healthcare experience in roles across the McKesson enterprise ranging from strategy to Six Sigma. “We’re looking forward to Jennifer joining the Augmedix board,” said Augmedix CEO Manny Krakaris. “Her expertise in healthcare, especially the strategic development of innovative organizations like Augmedix, will provide...

50 Most Influential Clinical Executives – 2020

Aledade CEO Farzad Mostashari, MD, has been named one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2020. The COVID-19 outbreak has been a stark reminder of how vital the healthcare industry is to local communities and the nation. Nobody knows this better than Aledade, which has been supporting primary care practices in its accountable care organizations through creating telehealth programs for independent primary care practices, keeping updated information about the regulatory landscape for telehealth, and sourcing $1 million in personal protective equipment to distribute...

‘Virtual’ drug research is becoming a permanent reality as the coronavirus upends clinical trials and fuels a new breed of startups

Coronavirus has caused hospitals to cancel all but the most urgent appointments, and doctors are turning to telemedicine to take care of their patients from a distance. But behind the scenes, the pandemic is also accelerating a fundamental shift in the typical expensive, sluggish way drugmakers test new medications on people—also known as clinical trials. Traditionally, in clinical trials, patients report regularly to hospitals or clinics for check-ins or to receive their treatments. When the coronavirus hit, some drug companies and health systems were forced to...